BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 24993295)

  • 1. Block of Kv4.3 potassium channel by trifluoperazine independent of CaMKII.
    Chae YJ; Choi BH; Choi JS; Hahn SJ
    Neurosci Lett; 2014 Aug; 578():159-64. PubMed ID: 24993295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of haloperidol on Kv4.3 potassium channels.
    Lee HJ; Sung KW; Hahn SJ
    Eur J Pharmacol; 2014 Oct; 740():1-8. PubMed ID: 24998874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Block of cloned Kv4.3 potassium channels by dapoxetine.
    Jeong I; Kim SW; Yoon SH; Hahn SJ
    Neuropharmacology; 2012 Jun; 62(7):2261-6. PubMed ID: 22192593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Open channel block of A-type, kv4.3, and delayed rectifier K+ channels, Kv1.3 and Kv3.1, by sibutramine.
    Kim SE; Ahn HS; Choi BH; Jang HJ; Kim MJ; Rhie DJ; Yoon SH; Jo YH; Kim MS; Sung KW; Hahn SJ
    J Pharmacol Exp Ther; 2007 May; 321(2):753-62. PubMed ID: 17312186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Raloxifene inhibits cloned Kv4.3 channels in an estrogen receptor-independent manner.
    Chae YJ; Kim DH; Lee HJ; Sung KW; Kwon OJ; Hahn SJ
    Pflugers Arch; 2015 Aug; 467(8):1663-76. PubMed ID: 25231973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Kv4.3 by genistein via a tyrosine phosphorylation-independent mechanism.
    Kim HJ; Ahn HS; Choi BH; Hahn SJ
    Am J Physiol Cell Physiol; 2011 Mar; 300(3):C567-75. PubMed ID: 21148405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of riluzole with the closed inactivated state of Kv4.3 channels.
    Ahn HS; Kim SE; Jang HJ; Kim MJ; Rhie DJ; Yoon SH; Jo YH; Kim MS; Sung KW; Hahn SJ
    J Pharmacol Exp Ther; 2006 Oct; 319(1):323-31. PubMed ID: 16815868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duloxetine blocks cloned Kv4.3 potassium channels.
    Choi JS; Hahn SJ
    Brain Res; 2012 Jul; 1466():15-23. PubMed ID: 22618310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of ranolazine on cloned cardiac kv4.3 potassium channels.
    Kim HJ; Ahn HS; Choi JS; Choi BH; Hahn SJ
    J Pharmacol Exp Ther; 2011 Dec; 339(3):952-8. PubMed ID: 21940646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of mosapride on Kv4.3 potassium channels expressed in CHO cells.
    Sung KW; Hahn SJ
    Naunyn Schmiedebergs Arch Pharmacol; 2013 Oct; 386(10):905-16. PubMed ID: 23793103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dihydropyridine Ca2+ channel antagonists and agonists block Kv4.2, Kv4.3 and Kv1.4 K+ channels expressed in HEK293 cells.
    Hatano N; Ohya S; Muraki K; Giles W; Imaizumi Y
    Br J Pharmacol; 2003 Jun; 139(3):533-44. PubMed ID: 12788813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of human Kv4.3/KChIP2 channel inactivation kinetics by cytoplasmic Ca
    Groen C; Bähring R
    Pflugers Arch; 2017 Nov; 469(11):1457-1470. PubMed ID: 28735419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Kv4.3 potassium channels by trazodone.
    Chae YJ; Choi JS; Hahn SJ
    Naunyn Schmiedebergs Arch Pharmacol; 2013 Aug; 386(8):711-9. PubMed ID: 23615873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of Kv4.3 currents by Ca2+/calmodulin-dependent protein kinase II.
    Sergeant GP; Ohya S; Reihill JA; Perrino BA; Amberg GC; Imaizumi Y; Horowitz B; Sanders KM; Koh SD
    Am J Physiol Cell Physiol; 2005 Feb; 288(2):C304-13. PubMed ID: 15456698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trifluoperazine blocks the human cardiac sodium channel, Na
    Kim DH; Lee SJ; Hahn SJ; Choi JS
    Biochem Biophys Res Commun; 2016 Oct; 479(3):584-589. PubMed ID: 27666479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The calmodulin inhibitor and antipsychotic drug trifluoperazine inhibits voltage-dependent K+ channels in rabbit coronary arterial smooth muscle cells.
    Hong DH; Son YK; Li H; Jung ID; Park YM; Jung WK; Kim HS; Choi IW; Park WS
    Biochem Biophys Res Commun; 2014 Jan; 443(1):321-5. PubMed ID: 24316213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hippocampal A-type current and Kv4.2 channel modulation by the sulfonylurea compound NS5806.
    Witzel K; Fischer P; Bähring R
    Neuropharmacology; 2012 Dec; 63(8):1389-403. PubMed ID: 22964468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diltiazem inhibits hKv1.5 and Kv4.3 currents at therapeutic concentrations.
    Caballero R; Gómez R; Núñez L; Moreno I; Tamargo J; Delpón E
    Cardiovasc Res; 2004 Dec; 64(3):457-66. PubMed ID: 15537499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of the transient outward current (Ito) in rat cardiac myocytes and human Kv4.3 channels by mefloquine.
    Perez-Cortes EJ; Islas AA; Arevalo JP; Mancilla C; Monjaraz E; Salinas-Stefanon EM
    Toxicol Appl Pharmacol; 2015 Oct; 288(2):203-12. PubMed ID: 26216464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arachidonic acid potently inhibits both postsynaptic-type Kv4.2 and presynaptic-type Kv1.4 IA potassium channels.
    Angelova PR; Müller WS
    Eur J Neurosci; 2009 May; 29(10):1943-50. PubMed ID: 19453640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.